EGFR and lung carcinoma: Recently, increasing numbers of miRNAs have been correlated with the drug resistance of lung cancer cells to anti-EGFR agents, indicating that miRNAs may serve as novel targets or promising predictive biomarkers for anti-EGFR therapy.